Larry K. Truesdale, Ph.D.
Dr. Larry K. Truesdale is Senior Director, External Research & Development Innovation at Pfizer Inc. In this role, Dr. Truesdale assists Pfizer with finding and evaluating new technologies for drug discovery. Prior to this position, Dr. Truesdale served in various management roles at Alanex, Agouron and Warner Lambert, which over the course of three acquisitions ultimately became Pfizer.
Dr. Truesdale was Director of Combinatorial Chemistry Technology at Alanex, where he was responsible for developing a viable combinational chemistry technology platform to be used in drug discovery. The resulting technology was used for reliable library production, high throughput analysis and purification.
Dr. Truesdale also was a Section Manager in Process Chemistry at Rhone-Poulenc Rorer, and has held management positions at Sphynx Pharmaceuticals Corp., Hyperion Catalysis International and Hoffman-LaRoche. Dr. Truesdale has taught chemistry as an adjunct professor at San Diego State University and Rutgers University.
He has authored numerous publications and is an inventor on more than a dozen patents and patent applications.
Dr. Truesdale earned a Ph.D. in chemistry from the University of California, Los Angeles and was a Post-Doctoral Fellow at the Massachusetts Institute of Technology.
